Pages that link to "Q37760090"
Jump to navigation
Jump to search
The following pages link to The clinical significance of hyperfiltration in diabetes (Q37760090):
Displaying 50 items.
- Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review (Q26863666) (← links)
- Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents (Q27010669) (← links)
- Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review (Q28079134) (← links)
- Associations between arsenic species in exfoliated urothelial cells and prevalence of diabetes among residents of Chihuahua, Mexico (Q28395150) (← links)
- Early chronic low-level lead exposure produces glomerular hypertrophy in young C57BL/6J mice (Q28397738) (← links)
- Annual deterioration of renal function in hypertensive patients with and without diabetes. (Q33875371) (← links)
- Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus. (Q34828258) (← links)
- Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes (Q34976710) (← links)
- Glomerular Hyperfiltration and Renal Progression in Children with Autosomal Dominant Polycystic Kidney Disease (Q35267170) (← links)
- Chaperonin-containing t-complex protein-1 subunit β as a possible biomarker for the phase of glomerular hyperfiltration of diabetic nephropathy (Q35470865) (← links)
- Renal hyperfiltration related to diabetes mellitus and obesity in human disease (Q35673442) (← links)
- Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells (Q35683125) (← links)
- Correlation of Microalbuminuria with Estimated GFR (eGFR) by Cockcroft-Gault and MDRD Formula in Type 2 Diabetics and Hypertensives (Q35747129) (← links)
- Microvascular disease precedes the decline in renal function in the streptozotocin-induced diabetic rat. (Q35780734) (← links)
- Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes (Q35797913) (← links)
- Association of Glomerular Filtration Rate with Inflammation in Polycystic Ovary Syndrome (Q35898943) (← links)
- Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy (Q35937053) (← links)
- Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy (Q36142232) (← links)
- Glomerular hyperfiltration and renal disease progression in type 2 diabetes (Q36249519) (← links)
- Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study (Q36764977) (← links)
- Early diabetic kidney maintains the corticomedullary urea and sodium gradient. (Q36773716) (← links)
- Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy (Q36876230) (← links)
- Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan (Q36970073) (← links)
- Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney (Q37253944) (← links)
- The renal effects of SGLT2 inhibitors and a mini-review of the literature (Q37632127) (← links)
- HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection (Q37679165) (← links)
- Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort. (Q37734623) (← links)
- Diabetic kidney disease with and without albuminuria (Q37855478) (← links)
- Effects of renal denervation on insulin resistance. (Q38067774) (← links)
- Pathophysiology of the diabetic kidney. (Q38111707) (← links)
- Hypoxia in diabetic kidneys (Q38233058) (← links)
- Updating the natural history of diabetic nephropathy (Q38258271) (← links)
- Extra-glycaemic properties of empagliflozin. (Q38494441) (← links)
- Less known pathophysiological mechanisms of anemia in patients with diabetic nephropathy (Q38504920) (← links)
- Update on Estimation of Kidney Function in Diabetic Kidney Disease. (Q38549960) (← links)
- Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies (Q38709338) (← links)
- The use of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and hypertension: a focus on African-American populations (Q38870752) (← links)
- Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes (Q39039079) (← links)
- Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment (Q39112475) (← links)
- Association of Increasing GFR with Change in Albuminuria in the General Population (Q40561359) (← links)
- Increased risk of glomerular hyperfiltration in subjects with impaired glucose tolerance and newly diagnosed diabetes (Q41094401) (← links)
- Hyperfiltration in Indigenous Australians with and without diabetes. (Q41613224) (← links)
- Structural Predictors of Renal Function Decline (Q42551126) (← links)
- Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. (Q42778066) (← links)
- Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy? (Q43803501) (← links)
- Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration (Q44189380) (← links)
- A longitudinal assessment of the natural rate of decline in renal function with age. (Q44221820) (← links)
- Nephrinuria associates with multiple renal traits in type 2 diabetes (Q44792460) (← links)
- Estimated glomerular filtration rate and its association with the retinol-binding protein 4 (RBP4) locus on human chromosome 10q23 (Q44882888) (← links)
- Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes (Q45091047) (← links)